Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: Current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation

Oncologist

Volumn 16, Issue 5, 2011, Pages 602-613

  Niederle, Martin B ^a   Niederle, Bruno ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Diagnosis and treatment; Gastrointestinal tract; Neuroendocrine tumors; Prospective clinical trial

Indexed keywords

ANTINEOPLASTIC AGENT; INTERFERON; SOMATOSTATIN DERIVATIVE;

ABDOMINAL PAIN; ADENOCARCINOMA; ADULT; ARTICLE; ASPIRATION BIOPSY; AUSTRIA; AUTOPSY; CANCER CLASSIFICATION; CANCER PALLIATIVE THERAPY; CANCER THERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIARRHEA; ENDOSCOPY; FLUSHING; FOLLOW UP; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE OBSTRUCTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; METASTASIS; MULTICENTER STUDY; NEUROENDOCRINE TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SYMPTOMATOLOGY; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

AUSTRIA; COLONIC NEOPLASMS; DISEASE PROGRESSION; HUMANS; ILEAL NEOPLASMS; INTESTINAL NEOPLASMS; JEJUNAL NEOPLASMS; MULTICENTER STUDIES AS TOPIC; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 79956260242     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0002     Document Type: Article

References (34)

1. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification. Ann N Y Acad Sci 2004;1014:13-27.
2. Klöppel G, Couvelard A, Perren A et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009;90:162-166.
3. Niederle MB, Hackl M, Kaserer K et al. Gastroenteropancreatic neuroendocrine tumours: The current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: An analysis based on prospectively collected parameters. Endocr Relat Cancer 2010; 17:909-918.
4. Solcia E, Kloppel G, Sobin L eds. Histological Typing of Endocrine Tumours, Second Edition. World Health Organization International Histological Classification of Tumours. Berlin: Springer, 2000:1-156.
5. Rindi G, Klöppel G, Alhman H et al. TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2006;449:395-401.
6. Rindi G, Klöppel G, Couvelard A et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2007;451:757-762.
7. Bosman F, Carneiro F, Hruban R et al., eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press, 2010:1-418.
8. Ruszniewski P, Delle Fave G, Cadiot G et al. Well-differentiated gastric tumors/carcinomas. Neuroendocrinology 2006;84:158-164.
9. Schindl M, Kaczirek K, Kaserer K et al. Is the new classification of neuroendocrine pancreatic tumors of clinical help? World J Surg 2000;24: 1312-1318.
10. Schindl M, Kaczirek K, Passler C et al. Treatment of small intestinal neuroendocrine tumors: Is an extended multimodal approach justified? World J Surg 2002;26:976-984.
11. Landerholm K, Falkmer S, Järhult J. Epidemiology of small bowel carcinoids in a defined population. World J Surg 2010;34:1500-1505.
12. Aggarwal G, Obideen K, Wehbi M. Carcinoid tumors: What should increase our suspicion? Cleve Clin J Med 2008;75:849-855.
13. Pape UF, Böhmig M, Berndt U et al. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a German referral center. Ann N Y Acad Sci 2004;1014:222-233.
14. Lombard-Bohas C, Mitry E, O'Toole D et al. Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France. Neuroendocrinology 2009;89:217-222.
15. Ploeckinger U, Kloeppel G, Wiedenmann B et al. The German NET registry: An audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 2009;90:349-363.
16. Eriksson B, Klöppel G, Krenning E et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors-well-differentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology 2008;87:8-19.
17. Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J Clin Gastroenterol 1993; 16:123-129.
18. Halfdanarson TR, Rubin J, Farnell MB et al. Pancreatic endocrine neoplasms: Epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 2008;15:409-427.
19. Pinchot SN, Holen K, Sippel RS et al. Carcinoid tumors. The Oncologist 2008;13:1255-1269.
20. Klöppel G, Clemens A. The biological relevance of gastric neuroendocrine tumors. Yale J Biol Med 1996;69:69-74.
21. Rindi G, Luinetti O, Cornaggia M et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study. Gastroenterology 1993;104:994-1006.
22. Borch K, Ahrén B, Ahlman H et al. Gastric carcinoids: Biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 2005;242:64-73.
23. Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment. Arch Surg 2001;136:49-54.
24. Plöckinger U, Rindi G, Arnold R et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424.
25. Deschamps L, Couvelard A. Endocrine tumors of the appendix: A pathologic review. Arch Pathol Lab Med 2010;134:871-875.
26. Plöckinger U, Couvelard A, Falconi M et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: Welldifferentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology 2008;87:20-30.
27. Ramage JK, Goretzki PE, Manfredi R et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: Welldifferentiated colon and rectum tumour/carcinoma. Neuroendocrinology 2008;87:31-39.
28. Schindl M, Niederle B, Häfner M et al. Stage-dependent therapy of rectal carcinoid tumors. W J Surg 1998;22:628-633; discussion 634.
29. Ahlman H, Nilsson O, McNicol AM et al. Poorly-differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology 2008;87:40-46.
30. Fendrich V, Waldmann J, Bartsch DK et al. Multiple primary malignancies in patients with sporadic pancreatic endocrine tumors. J Surg Oncol 2008; 97:592-595.
31. Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000;75:310-316.
32. Tichansky DS, Cagir B, Borrazzo E et al. Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum 2002;45:91-97.
33. Li AF, Hsu CY, Li A et al. A 35-year retrospective study of carcinoid tumors in Taiwan: Differences in distribution with a high probability of associated second primary malignancies. Cancer 2008;112:274-283.
34. Brune M, Gerdes B, Koller M et al. [Neuroendocrine tumors of the gastrointestinal tract (NETGI) and second primary malignancies-which is dominant?] Dtsch Med Wochenschr 2003;128:2413-2417.